FDA Approves First and Only Weekly Diabetes 2 Shot Therapy in the US
Bydureon took three tries to make it through approval with the FDA. …
Key Recent Developments in Diabetes Research
Two noteworthy developments in the study of diabetes came to light today.…
Health Affairs Briefing Addresses Costly Consequences of Diabetes Treatment in America
This week I was honored to participate in a panel discussion at…
Medicaid Expansion: Will We get our Money’s Worth?
Should we just hand uninsured adult diabetics $1000 per year rather than…
3 Factors Fueling Growth in Mobile Health Apps
The market for mobile health apps is forecast to grow 70%…
Thermalin Diabetes Follows the “Coulter Process” And Addresses Significant Needs in the Insulin Market
According to Rick Berenson, CEO of Thermalin Diabetes, insulin is a $14B…
GlySure Develops a Continuous Glucose Monitoring System
GlySure Limited is a privately held company that has developed The GlySure…
